No data to show
XJPX
4558
Market cap15mUSD
Sep 19, Last price
215.00JPY
1D
1.90%
1Q
6.44%
Jan 2017
-24.56%
Name
Chukyoiyakuhin Co Ltd
Chart & Performance
P/E
50.65
P/S
0.36
EPS
4.24
Div Yield, %
2.33%
Shrs. gr., 5y
4.82%
Rev. gr., 5y
-2.51%
Revenues
6.31b
+2.97%
Net income
45m
P
CFO
32m
-81.55%
Dividend
Sep 29, 20250 JPY/sh
Profile
Chukyoiyakuhin Co.,Ltd. engages in the pharmaceuticals, health food products, soft drinks, medical equipment, cosmetics, daily necessities, clothing, food, and life and non-life insurance business. It is also involved in the manufacture and sale of quasi-drugs; production and sale of water; and manufacture and sale of alcohol products for sterilization. The company was founded in 1949 and is headquartered in Handa, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | ||||||
Revenues | 6,306,646 2.97% | 6,124,622 7.59% | 5,692,647 6.28% | |||
Cost of revenue | 3,042,708 | 2,741,320 | 2,307,187 | |||
Unusual Expense (Income) | ||||||
NOPBT | 3,263,938 | 3,383,302 | 3,385,460 | |||
NOPBT Margin | 51.75% | 55.24% | 59.47% | |||
Operating Taxes | 80,638 | 47,571 | 62,880 | |||
Tax Rate | 2.47% | 1.41% | 1.86% | |||
NOPAT | 3,183,300 | 3,335,731 | 3,322,580 | |||
Net income | 45,148 -265.27% | (27,318) -288.57% | 14,487 -56.39% | |||
Dividends | (54,382) | (54,542) | (54,115) | |||
Dividend yield | 2.48% | 2.43% | 2.27% | |||
Proceeds from repurchase of equity | (36) | (15) | 664 | |||
BB yield | 0.00% | 0.00% | -0.03% | |||
| Debt | ||||||
Debt current | 921,604 | 1,139,302 | 1,045,195 | |||
Long-term debt | 432,449 | 86,167 | 250,848 | |||
Deferred revenue | (58,749) | |||||
Other long-term liabilities | 388,897 | 381,920 | 374,362 | |||
Net debt | (58,977) | 65,351 | (171,245) | |||
| Cash flow | ||||||
Cash from operating activities | 31,708 | 171,853 | 105,833 | |||
CAPEX | (25,608) | (36,683) | (191,833) | |||
Cash from investing activities | 53,355 | (36,046) | (199,959) | |||
Cash from financing activities | 42,967 | (131,269) | (247,069) | |||
FCF | 3,155,790 | 3,348,299 | 3,337,460 | |||
| Balance | ||||||
Cash | 1,235,465 | 1,107,433 | 1,102,892 | |||
Long term investments | 177,565 | 52,685 | 364,396 | |||
Excess cash | 1,097,698 | 853,887 | 1,182,656 | |||
Stockholders' equity | 1,567,546 | 1,483,148 | 2,422,727 | |||
Invested Capital | 3,138,355 | 3,242,506 | 2,902,622 | |||
ROIC | 99.78% | 108.57% | 112.66% | |||
ROCE | 77.05% | 82.59% | 81.69% | |||
| EV | ||||||
Common stock shares outstanding | 10,655 | 10,647 | 10,633 | |||
Price | 206.00 -2.37% | 211.00 -5.80% | 224.00 -16.73% | |||
Market cap | 2,194,930 -2.30% | 2,246,517 -5.68% | 2,381,792 -15.74% | |||
EV | 2,135,953 | 2,311,868 | 2,210,547 | |||
EBITDA | 3,361,843 | 3,480,579 | 3,476,223 | |||
EV/EBITDA | 0.64 | 0.66 | 0.64 | |||
Interest | 8,846 | 3,950 | 4,358 | |||
Interest/NOPBT | 0.27% | 0.12% | 0.13% | |||